Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TLR7 and TLR8 as targets in cancer therapy
Michael P. Schön, Michael P. Schön
Oncogene (2008) Vol. 27, Iss. 2, pp. 190-199
Closed Access | Times Cited: 283

Showing 26-50 of 283 citing articles:

Triggering TLR7 in mice induces immune activation and lymphoid system disruption, resembling HIV-mediated pathology
Stefan Baenziger, Mathias Heikenwälder, Pål Johansen, et al.
Blood (2008) Vol. 113, Iss. 2, pp. 377-388
Open Access | Times Cited: 142
Phase I Study Utilizing a Novel Antigen-Presenting Cell–Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
Michael A. Morse, Robert Chapman, John D. Powderly, et al.
Clinical Cancer Research (2011) Vol. 17, Iss. 14, pp. 4844-4853
Open Access | Times Cited: 141
Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma
Simon J. Dovedi, Monique Melis, Robert W. Wilkinson, et al.
Blood (2012) Vol. 121, Iss. 2, pp. 251-259
Open Access | Times Cited: 140
Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
Hailing Lu, Yi Yang, Ekram Gad, et al.
Clinical Cancer Research (2010) Vol. 17, Iss. 1, pp. 67-76
Open Access | Times Cited: 137
Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
Paul J. Tacken, Carl G. Figdor
Seminars in Immunology (2011) Vol. 23, Iss. 1, pp. 12-20
Closed Access | Times Cited: 133
TLR-3 Stimulation Skews M2 Macrophages to M1 Through IFN-αβ Signaling and Restricts Tumor Progression
Aurobind Vidyarthi, Nargis Khan, Tapan Agnihotri, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 128
In Vitro Analysis of Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine Adjuvants
Eric M. Bachelder, Tristan T. Beaudette, Kyle E. Broaders, et al.
Molecular Pharmaceutics (2010) Vol. 7, Iss. 3, pp. 826-835
Open Access | Times Cited: 125
Modulation of γδ T cell responses by TLR ligands
Daniela Wesch, Christian Peters, Hans‐Heinrich Oberg, et al.
Cellular and Molecular Life Sciences (2011) Vol. 68, Iss. 14, pp. 2357-2370
Open Access | Times Cited: 114
Small-molecule inhibition of TLR8 through stabilization of its resting state
Shuting Zhang, Zhenyi Hu, Hiromi Tanji, et al.
Nature Chemical Biology (2017) Vol. 14, Iss. 1, pp. 58-64
Open Access | Times Cited: 110
Trial Watch: Peptide-based anticancer vaccines
Jonathan Pol, Norma Bloy, Aitziber Buqué, et al.
OncoImmunology (2015) Vol. 4, Iss. 4, pp. e974411-e974411
Open Access | Times Cited: 108
Lyophilizable and Multifaceted Toll-like Receptor 7/8 Agonist-Loaded Nanoemulsion for the Reprogramming of Tumor Microenvironments and Enhanced Cancer Immunotherapy
Sunyoung Kim, Sohyun Kim, Jung‐Eun Kim, et al.
ACS Nano (2019) Vol. 13, Iss. 11, pp. 12671-12686
Closed Access | Times Cited: 108
Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles
Ana Bocanegra, Ane Ruiz‐de‐Angulo, Aintzane Zabaleta, et al.
Biomaterials (2018) Vol. 170, pp. 95-115
Open Access | Times Cited: 94
Toll-like Receptor Agonist Conjugation: A Chemical Perspective
Bob J. Ignacio, Tyler J. Albin, Aaron P. Esser‐Kahn, et al.
Bioconjugate Chemistry (2018) Vol. 29, Iss. 3, pp. 587-603
Open Access | Times Cited: 89
Immune precision medicine for cancer: a novel insight based on the efficiency of immune effector cells
Jean‐François Rossi, Patrice Céballos, Zhao‐Yang Lu
Cancer Communications (2019) Vol. 39, Iss. 1, pp. 1-16
Open Access | Times Cited: 83
A microparticle platform for STING-targeted immunotherapy enhances natural killer cell- and CD8+ T cell-mediated anti-tumor immunity
Rebekah Watkins-Schulz, Pamela Tiet, Matthew D. Gallovic, et al.
Biomaterials (2019) Vol. 205, pp. 94-105
Open Access | Times Cited: 82
Sono/Photodynamic Nanomedicine‐Elicited Cancer Immunotherapy
Yuce Li, Jun Xie, Wooram Um, et al.
Advanced Functional Materials (2020) Vol. 31, Iss. 12
Closed Access | Times Cited: 80
Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
Qinjun Chen, Tao Sun, Chen Jiang
Nano-Micro Letters (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 76
Toll-Like Receptors as a Therapeutic Target in the Era of Immunotherapies
Mariya Farooq, Maria Batool, Moon Suk Kim, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 71
Recent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy
Benqing Zhou, Jinxing Liu, Meiai Lin, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 214009-214009
Closed Access | Times Cited: 59
Macrophage-targeted nanomedicine for chronic diseases immunotherapy
Yuejia Song, Yaqian Huang, Fang Zhou, et al.
Chinese Chemical Letters (2021) Vol. 33, Iss. 2, pp. 597-612
Closed Access | Times Cited: 56
Updated Perspectives on Keratinocytes and Psoriasis: Keratinocytes are More Than Innocent Bystanders
Laura I Ortiz-Lopez, Vivek Choudhary, Wendy B. Bollag
Psoriasis Targets and Therapy (2022) Vol. Volume 12, pp. 73-87
Open Access | Times Cited: 54
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
Prashant Sharma, Mario Otto
Bioactive Materials (2023) Vol. 31, pp. 440-462
Open Access | Times Cited: 32
Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy
Asif Mohd Itoo, Balaram Ghosh, Swati Biswas
Coordination Chemistry Reviews (2024) Vol. 508, pp. 215796-215796
Closed Access | Times Cited: 9
Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors
Hao Li, Shuai Wang, Zhengqiang Yang, et al.
Bioactive Materials (2024) Vol. 36, pp. 376-412
Open Access | Times Cited: 8
Revolutionizing lymph node metastasis imaging: the role of drug delivery systems and future perspectives
Ze‐Min Cai, Zi‐Zhan Li, Nian‐Nian Zhong, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 8

Scroll to top